Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
71 hedge funds and large institutions have $126M invested in Gritstone bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 16 closing their positions.
108% more capital invested
Capital invested by funds: $60.3M → $126M (+$65.2M)
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
3% more funds holding
Funds holding: 69 → 71 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$10.3M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$8.15M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$6.42M |
| 4 |
VVM
Versant Venture Management
San Francisco,
California
|
+$4.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Alphabet Inc
Mountain View,
California
|
-$1.45M |
| 2 |
BlackRock
New York
|
-$1.43M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$598K |
| 4 |
BL
Bleichroeder LP
New York
|
-$448K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$365K |
GRTS Hedge Fund Activity: Q4 2020 in Review
71 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2020, worth a combined $126M — up 108% from $60.3M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new GRTS positions and 16 closed out — a net gain of 3 holders — while 21 added to existing stakes and 21 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $10.3M. The largest seller was Alphabet Inc, exiting entirely with an estimated $1.45M sold.
- 71 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2020, up from 69 in Q3 2020.
- Funds reported $126M of Gritstone bio, Inc. Common Stock stock for Q4 2020, up 108% quarter-over-quarter.
- 19 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2020 and 16 closed out, a net change of +3 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q4 2020 was EcoR1 Capital, an estimated $10.3M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q4 2020 was Alphabet Inc, an estimated $1.45M sold.
Based on aggregated 13F filings for Q4 2020.